object(WP_Post)#1548 (24) { ["ID"]=> int(2774) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2017-02-16 17:11:25" ["post_date_gmt"]=> string(19) "2017-02-16 17:11:25" ["post_content"]=> string(498) "FDNA provides tools and information to gain detailed and customizable analytics of the rare disease and genetic disease markets. Market analysts and life science marketing departments, among others, can poll clinicians globally or query FDNA’s de-identified, aggregated database to access insights on rare and genetic diseases. Whether searching for real-world data on diagnostic and treatment behavior or learning where various syndromes are being diagnosed, FDNA can give you access to answers." ["post_title"]=> string(27) "Polling and Market Research" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(36) "genetic-rare-disease-market-research" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2017-03-15 01:31:32" ["post_modified_gmt"]=> string(19) "2017-03-15 01:31:32" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(50) "http://dev-fdna-site.pantheonsite.io/?page_id=2774" ["menu_order"]=> int(0) ["post_type"]=> string(4) "page" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

FDNA provides tools and information to gain detailed and customizable analytics of the rare disease and genetic disease markets. Market analysts and life science marketing departments, among others, can poll clinicians globally or query FDNA’s de-identified, aggregated database to access insights on rare and genetic diseases. Whether searching for real-world data on diagnostic and treatment behavior or learning where various syndromes are being diagnosed, FDNA can give you access to answers.

Get Started

CONTACT US

2000+ institutions in 100+ countries

  • Poll clinicians
  • Population data for syndromes and healthcare access
  • Refinement by criteria such as demographics, phenotypes and genetics
Share this page
Share on FacebookShare on LinkedInTweet about this on TwitterShare on Google+Email this to someone